Round up

Age

3 years

Released:2016-09-26

Available in

0 Countries

of 155 total

Activity

0

last updated: n/a

Overall Ratings

n/a

Global Rank

None

Currently not visible

Top 25 Overall

0 Countries

Not in any top 25

Global Rank Positions
Description
Read more
The clinical symptoms of neurodegenerative diseases arise years after the onset of neuronal damage. By the time the patient receives a diagnosis, it might be too late to intervene and modify the advanced pathological state of disease. Researchers are now focusing on preventing and stopping the pathological processes in the brain at an earlier, asymptomatic state.
This conference aims to disseminate cutting-edge findings on preclinical neurodegenerative diseases—including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and Huntington’s disease. The event will provide a unique platform for specialists to come together across disciplines for an authoritative discussion of the methodological, regulatory, and ethical considerations of research in people at asymptomatic states of neurodegenerative disease.
A high level invited oral programme, supplemented by contributed posters will provide a complete update on the latest research and thinking on the following topics:
•Genetic factors, cellular pathways, and neuronal vulnerability
•Environmental factors, epidemiology, and primary prevention
•Biomarkers and early diagnosis
•Prevention through therapeutics
•Trials; regulatory and ethical considerations
The event will also have a translational focus, exploring genetic susceptibility, epidemiology and risk factors, neuronal vulnerability, biomarkers and early diagnosis, and disease prevention in healthy individuals with both pharmacological and non-pharmacological interventions.
Attendance at this meeting will enable you to:
•Be part of a rich scientific programme incorporating the latest developments in preclinical neurodegenerative diseases
•Understand the shift towards prevention and early diagnosis of neurodegenerative disease as the future of research in the field
•Join key opinion leaders in discussing regulatory and ethical implications of this research in clinical practice.
•Network with speakers and other leading experts across disciplines.

Using Elsevier's new NEUROLOGY16 app, you can browse the scientific programme by days, topic or speaker, create your own personal programme, locate rooms and exhibitor stands on the floor plans, and more. Before first use, you will need to download the latest conference data and then afterwards, you can use the app offline.
Screenshots
Read more
Ratings
more
Versions
Read more